Benign Ethnic Neutropenia: An Avoidable Obstacle to Clozapine Use
DOI:
https://doi.org/10.20344/amp.24904Keywords:
Antipsychotic Agents/adverse effects, Clozapine/adverse effects, Clozapine/therapeutic use, Ethnicity, Neutropenia/chemically induced, Neutropenia/ethnologyAbstract
n/a.
Downloads
References
Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019;37:100586. DOI: https://doi.org/10.1016/j.blre.2019.06.003
Ribeiro ML, Albuquerque S, Saraiva R, Coentre R. Benign ethnic neutropenia and clozapine. Prim Care Companion CNS Disord. 2026;28:25cr04053. DOI: https://doi.org/10.4088/PCC.25cr04053
Oloyede E, Casetta C, Dzahini O, Segev A, Gaughran F, Shergill S, et al. Life after the UK clozapine central non-rechallenge database: a national perspective. Schizophr Bull. 2021;47:1088-98. DOI: https://doi.org/10.1093/schbul/sbab006
Wu S, Powell V, Chintoh A, Alarabi M, Agarwal S, Remington G. Safety of BEN guidelines in clozapine treatment: a Canadian perspective. Schizophr Res. 2024;264:451-6. DOI: https://doi.org/10.1016/j.schres.2024.01.021
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.



